MDLN
Medline Inc. Class A Common Stock
NASDAQ: MDLN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$43.40
-1.90% today
Updated 2026-04-29
Market cap
$36.70B
P/E ratio
30.35
P/S ratio
1.29x
EPS (TTM)
$1.43
Dividend yield
—
52W range
$35 – $51
Volume
6.6M
Medline Inc. Class A Common Stock (MDLN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $21.45B | $23.23B | $25.51B | $28.43B |
| Revenue growth (YoY) | — | +8.3% | +9.8% | +11.5% |
| Cost of revenue | $16.89B | $18.01B | $19.22B | $20.91B |
| Gross profit | $4.56B | $5.22B | $6.29B | $7.52B |
| Gross margin | 21.2% | 22.5% | 24.7% | 26.4% |
| R&D | $58.00M | $60.00M | $67.00M | — |
| SG&A | — | — | — | $4.52B |
| Operating income | $870.00M | $1.44B | $2.23B | $2.21B |
| Operating margin | 4.1% | 6.2% | 8.7% | 7.8% |
| EBITDA | $1.85B | $2.59B | $3.53B | $2.92B |
| EBITDA margin | 8.6% | 11.1% | 13.8% | 10.3% |
| EBIT | $921.00M | $1.64B | $2.56B | $2.21B |
| Interest expense | $911.00M | $1.38B | $1.31B | $812.00M |
| Income tax | $35.00M | $30.00M | $46.00M | — |
| Effective tax rate | 350.0% | 11.4% | 3.7% | 0.0% |
| Net income | $-25.00M | $234.00M | $1.20B | $1.16B |
| Net income growth (YoY) | — | +1036.0% | +412.8% | -3.4% |
| Profit margin | -0.1% | 1.0% | 4.7% | 4.1% |